Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers
J. E. Wiedmeier-Nutor et al · Nature Publishing Group · 2026
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
al, J. E. W. N. E. (2026). Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers. https://doi.org/10.1038/s41408-026-01508-9
MLA
al, J. E. Wiedmeier-Nutor et. "Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers." 2026. https://doi.org/10.1038/s41408-026-01508-9.
Chicago
al, J. E. Wiedmeier-Nutor et. 2026. "Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers.". https://doi.org/10.1038/s41408-026-01508-9.
Harvard
al, J. E. W. N. E. 2026, Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers, Nature Publishing Group, available at: https://doi.org/10.1038/s41408-026-01508-9 [Accessed 29 Jun. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers
- Autor / colaboradores
- J. E. Wiedmeier-Nutor et al
- Editorial
- Nature Publishing Group
- Año de publicación
- 2026
- ISSN
- 2044-5385
- ISSN
- 2044-5385
- Idioma
- eng